NCT02972593

Brief Summary

The purpose of this study is to determine if there is a difference in outcomes between liberal transfusion (transfusing when hemoglobin drops below a set higher value number) and conservative transfusion (transfusing when hemoglobin drops below a set lower value number).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
161

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2014

Longer than P75 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 23, 2016

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2022

Completed
1 year until next milestone

Results Posted

Study results publicly available

June 29, 2023

Completed
Last Updated

June 29, 2023

Status Verified

June 1, 2023

Enrollment Period

8.3 years

First QC Date

November 17, 2016

Results QC Date

June 6, 2023

Last Update Submit

June 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Wound Infection (Superficial or Deep) or Other Perioperative Infection

    Deep infection is defined as the need for intravenous antibiotics and/or a return to surgery for debridement. Superficial infection is defined as clinical diagnosis of cellulitis or other superficial infection treated with oral antibiotics only.

    one year

Secondary Outcomes (2)

  • Combined Secondary Outcomes

    one year

  • Musculoskeletal Function Assessment

    one year

Study Arms (2)

Liberal

OTHER

Blood and blood products for transfusion. Transfusion will be done to keep Hgb \>7 g/dL.

Biological: Blood and blood products for transfusion

Conservative

OTHER

Blood and blood products for transfusion. Transfusion will be done to keep Hgb \> 5.5 g/dL.

Biological: Blood and blood products for transfusion

Interventions

Randomization would not occur until the patient's Hgb dropped below 7 g/dL. If the patient is randomized to the liberal arm, they would be transfused to keep their Hgb \>7 g/dL. If the patient is randomized to the conservative arm, they would not be transfused until their Hgb drops below 5.5 g/dL. If the patient's Hgb does not drop below 7.0 g/dL, randomization will not be done.

ConservativeLiberal

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Trauma patients admitted to participating hospital with any Orthopaedic injury who have been determined to be stable by the Trauma Service (General Surgery) and are no longer within the resuscitation phase of initial treatment. This is defined as a normal urine output (greater than 0.5 ml/kg/hr) and a systolic blood pressure greater than 90 mmHg for greater than 6 hours without fluid bolus or transfusion during that time
  • Age 18-50
  • Hemoglobin less than 9 g/dL or expected drop below 9 g/dL with planned surgery

You may not qualify if:

  • Pregnant ( urine pregnancy test will be done as standard of care)
  • Prisoner
  • Head injury (Glasgow Coma Scale less than 8 over 48 hours from presentation)
  • Known cardiac (coronary artery disease, atrial fibrillation, stent placement, congestive heart failure), renal (acute or chronic renal insufficiency or failure, defined as having Serum Creatinine \>1.2 at time of enrollment), liver (Childs C cirrhosis) or pulmonary disease (chronic obstructive pulmonary disease, abnormal pulmonary function tests or history of poor pulmonary function from any cause including acute traumatic conditions such as ARDS)
  • Unlikely to follow up in the surgeon's estimation
  • Sickle Cell Anemia
  • History of cancer
  • Preexisting weakness, paresthesias, deformities, or other conditions which might affect functional outcome in the surgeon's opinion
  • Spinal cord injury
  • Patients with burns expected to require operative treatment
  • COVID positive

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Mullis BH, Mullis LS, Kempton LB, Virkus W, Slaven JE, Bruggers J. Early Results of Orthopaedic Trauma and Anemia: Conservative Versus Liberal Transfusion Strategy. J Am Acad Orthop Surg. 2024 Mar 1;32(5):228-235. doi: 10.5435/JAAOS-D-23-00235. Epub 2023 Dec 27.

  • Mullis BH, Mullis LS, Kempton LB, Virkus W, Slaven JE, Bruggers J. Orthopaedic Trauma and Anemia: Conservative versus Liberal Transfusion Strategy: A Prospective Randomized Study. J Orthop Trauma. 2024 Jan 1;38(1):18-24. doi: 10.1097/BOT.0000000000002696.

MeSH Terms

Conditions

Anemia

Interventions

Blood Specimen CollectionBlood Transfusion

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesBiological TherapyTherapeutics

Limitations and Caveats

Significant loss to follow up; Significant resistance by multiple providers at each site to allow conservative treatment algorithm (as most felt liberal was standard of care); Slow enrollment; No funding

Results Point of Contact

Title
Dr. Brian H. Mullis
Organization
Indiana University School of Medicine Department of Orthopaedic Surgery

Study Officials

  • Brian H Mullis, MD

    Indiana University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 17, 2016

First Posted

November 23, 2016

Study Start

March 1, 2014

Primary Completion

June 24, 2022

Study Completion

June 24, 2022

Last Updated

June 29, 2023

Results First Posted

June 29, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share